Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Propylene glycol and ethanol increase finasteride skin absorption, sodium lauryl sulfate doesn't.

Sandalore®, a synthetic scent, reduced hair loss and improved hair growth in women with telogen effluvium.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Eucalyptol and oleic acid in nanoemulsions improve minoxidil delivery to hair follicles, potentially enhancing hair loss treatment.

Tinea faciei should be considered in neonatal vesicular lesions and confirmed with KOH examination and culture.

Liposomes and niosomes improve finasteride delivery for hair loss treatment.

Chronic lupus and frontal fibrosing alopecia can occur together, but their connection is unclear.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Favus, a rare fungal infection, has reappeared in Japan.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

The document's conclusion cannot be provided because the text is not in a processable format.

New UVA-responsive nanocapsules effectively kill microorganisms in hair follicles when activated by light.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Chronic kidney disease can cause skin and nail problems.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Using tiny fat particles to deliver arginine to hair follicles could be a new way to treat hair loss.

Alefacept does not effectively treat severe alopecia areata.

Tofacitinib is an effective and safe treatment for alopecia areata.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Secukinumab effectively treated a difficult case of folliculitis decalvans.